David Gammon, BSPh

David Gammon, BSPH
David Gammond,BSPH
Instructor

Mr. Gammon is currently a Clinical Pharmacist at UMass Memorial Health Care, specializing in the care of Oncology/Hematology/BMT/Pediatric Oncology patients.  His clinical expertise includes training and educating Pharmacy Students and Residents in Hospital Pharmacy practice, proper Aseptic Technique, the handling of Cytotoxic Drugs, establishing policies and procedures for safe clean room operation and ensuring compliance with USP 797 and new NIOSH regulations. 

Education

2005 CITI (Course in the Protection of Human Research Subjects), NCI, Univ. of Miami
2003- Present ACLS Certified and Instructor for ACLS Pharmacology
1995- Present CPR Instructor
1994 ASHP Pharmacokinetic Certification Program
1981 University of Georgia College of Pharmacy, BSPh

Selected Publications

Gammond, D., (2006). Reduced-Dose Rasburicase in the Treatment of Adults with Hyperuricemia Associated with Malignancy: Pharmacotherapy, 26, (2), 242-247

Gammon, D et al. (2004). Hypersensitivity Reactions to Oxaliplatin and the Application of a Desensitization Protocol; The Oncologist, 9: 546-549

Gammon, D et al. (2004).  Superselective Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Experience with a New Emulsion, Lippincott’s Hospital Pharmacy, 39(9), 864-867

Gammon, D et al. (2004).  Safety and Cost-effectiveness of Paclitaxel Administered as a 1-Hour Infusion Versus a 3-Hour Infusion for Various Malignancies: Journal of Infusion Nursing, 27(4), 251-253

Bhargava, P, Gammon D (2004).  Correspondence: Hypersensitivity and Idiosyncratic Reactions to Oxaliplatin,  Cancer, 100(1), 211-212

Gammon, D et al. (2003).  Economic Implications of a Time Analysis: Zoledronic acid Versus Pamidronate Administration in the Outpatient Prevention of Hypercalcemia of Malignancy or Bone Metastases, Lippincott’s Hospital Pharmacy, 38(12), 1148-1150

Research Interests:

  • Novel Pharmaco-Therapeutics with existing drugs
  • Pharmaco-Economics